Acute Ischemic Stroke Intervention

Journal of the American College of Cardiology

Volumn 67, Issue 22, 2016, Pages 2631-2644

  Khandelwal, Priyank ^a   Yavagal, Dileep R ^b   Sacco, Ralph L ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

large vessel occlusion; mechanical thrombectomy; stent retrievers; stroke systems

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; SARUPLASE; TISSUE PLASMINOGEN ACTIVATOR;

BARE METAL STENT; BRAIN ISCHEMIA; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISABILITY; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG ELUTING STENT; HUMAN; MECHANICAL THROMBECTOMY; MORTALITY; MULTICENTER STUDY (TOPIC); NEUROIMAGING; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STENT RETRIEVER; THROMBECTOMY DEVICE; UNITED STATES; BRAIN; DEVICES; DIAGNOSTIC IMAGING; ENDOVASCULAR SURGERY; MAGNETIC RESONANCE ANGIOGRAPHY; STROKE; THROMBECTOMY; TIME TO TREATMENT; X-RAY COMPUTED TOMOGRAPHY;

BRAIN; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; THROMBECTOMY; TIME-TO-TREATMENT; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84977606075     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.555     Document Type: Review

References (57)

1. 1 Lloyd-Jones, D., Adams, R.J., Brown, T.M., et al., for the American Heart Association Stroke Council. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121 (2010), e46–e215.
2. 2 Del Zoppo, G.J., Saver, J.L., Jauch, E.C., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 40 (2009), 2945–2948.
3. 3 National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995), 1581–1587.
4. 4 Albers, G.W., Bates, V.E., Clark, W.M., et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283 (2000), 1145–1150.
5. 5 Wardlaw, J.M., Zoppo, G., Yamaguchi, T., et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, CD000213.
6. 6 Hacke, W., Kaste, M., Bluhmki, E., et al., for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359 (2008), 1317–1329.
7. 7 Powers, W.J., Derdeyn, C.P., Biller, J., et al., for the American Heart Association Stroke Council. 2015 AHA/ASA focused update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46 (2015), 3020–3035.
8. 8 Bluhmki, E., Chamorro, A., Davalos, A., et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol 8 (2009), 1095–1102.
9. 9 Albers, G.W., Olivot, J.M., Intravenous alteplase for ischaemic stroke. Lancet 369 (2007), 249–250.
10. 10 Saqqur, M., Uchino, K., Demchuk, A.M., et al., for the CLOTBUST Investigators. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 38 (2007), 948–954.
11. 11 Paciaroni, M., Balucani, C., Agnelli, G., et al. Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study. Stroke 43 (2012), 125–130.
12. 12 del Zoppo, G.J., Higashida, R.T., Furlan, A.J., et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 29 (1998), 4–11.
13. 13 Furlan, A., Higashida, R., Wechsler, L., et al., for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 282 (1999), 2003–2011.
14. 14 Adams, H., Adams, R., Del Zoppo, G., et al. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 36 (2005), 916–923.
15. 15 Jauch, E.C., Saver, J.L., Adams, H.P. Jr., et al., for the American Heart Association Stroke Council. Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, and Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44 (2013), 870–947.
16. 16 Smith, W.S., Sung, G., Starkman, S., et al., for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005), 1432–1438.
17. 17 Smith, W.S., Sung, G., Saver, J., et al., for the Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39 (2008), 1205–1212.
18. 18 Nogueira, R.G., Liebeskind, D.S., Sung, G., et al., for MERCI, and the Multi MERCI Writing Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI. Trials. Stroke 40 (2009), 3777–3783.
19. 19 Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40 (2009), 2761–2768.
20. 20 Broderick, J.P., Palesch, Y.Y., Demchuk, A.M., et al., for the Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 368 (2013), 893–903.
21. 21 Ciccone, A., Valvassori, L., Nichelatti, M., et al., for the SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med 368 (2013), 904–913.
22. 22 Kidwell, C.S., Jahan, R., Gornbein, J., et al., for the MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 368 (2013), 914–923.
23. 23 Nogueira, R.G., Lutsep, H.L., Gupta, R., et al., for the TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 380 (2012), 1231–1240.
24. 24 Saver, J.L., Jahan, R., Levy, E.I., et al., for the SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380 (2012), 1241–1249.
25. 25 Demchuk, A.M., Goyal, M., Yeatts, S.D., et al., for the IMS III Investigators. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology 273 (2014), 202–210.
26. 26 Wakhloo, A.K., Gounis, M.J., Retrievable closed cell intracranial stent for foreign body and clot removal. Neurosurgery 62 (2008), ONS390–ONS393 discussion ONS393–4.
27. 27 Berkhemer, O.A., Fransen, P.S., Beumer, D., et al., for the MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372 (2015), 11–20.
28. 28 Goyal, M., Demchuk, A.M., Menon, B.K., et al., for the ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372 (2015), 1019–1030.
29. 29 Saver, J.L., Goyal, M., Bonafe, A., et al., for the SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372 (2015), 2285–2295.
30. 30 Campbell, B.C., Mitchell, P.J., Kleinig, T.J., et al., for the EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372 (2015), 1009–1018.
31. 31 Campbell, B.C., Hill, M.D., Rubiera, M., et al. Safety and efficacy of solitaire stent thrombectomy: individual patient data meta-analysis of randomized trials. Stroke 47 (2016), 798–806.
32. 32 Jovin, T.G., Chamorro, A., Cobo, E., et al., for the REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372 (2015), 2296–2306.
33. 33 Barber, P.A., Demchuk, A.M., Zhang, J., et al., for the ASPECTS Study Group. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 355 (2000), 1670–1674.
34. 34 Wahlgren, N., Ahmed, N., Eriksson, N., et al., for the SITS-MOST Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 39 (2008), 3316–3322.
35. 35 Pexman, J.H., Barber, P.A., Hill, M.D., et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 22 (2001), 1534–1542.
36. 36 Hill, M.D., Demchuk, A.M., Goyal, M., et al., for the IMS3 Investigators. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke 45 (2014), 444–449.
37. 37 Menon, B.K., O'Brien, B., Bivard, A., et al. Assessment of leptomeningeal collaterals using dynamic CT angiography in patients with acute ischemic stroke. J Cereb Blood Flow Metab 33 (2013), 365–371.
38. 38 Lees, K.R., Bluhmki, E., von Kummer, R., et al., for the ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group Investigators. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375 (2010), 1695–1703.
39. 39 ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004), 768–774.
40. 40 Marler, J.R., Tilley, B.C., Lu, M., et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 55 (2000), 1649–1655.
41. 41 Khatri, P., Abruzzo, T., Yeatts, S.D., et al., for the IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 73 (2009), 1066–1072.
42. 42 Khatri, P., Yeatts, S.D., Mazighi, M., et al., for the IMS III Trialists. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol 13 (2014), 567–574.
43. 43 Menon, B.K., Almekhlafi, M.A., Pereira, V.M., et al., for the STAR Study Investigators. Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR Thrombectomy for Acute Revascularization study. Stroke 45 (2014), 2024–2029.
44. 44 Tomsick, T., TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 28 (2007), 382–384.
45. 45 Lansberg, M.G., Straka, M., Kemp, S., et al., for the DEFUSE 2 Study Investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 11 (2012), 860–867.
46. 46 GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993), 1615–1622.
47. 47 Stone, G.W., Grines, C.L., Cox, D.A., et al., for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002), 957–966.
48. 48 Mehta, R.H., Harjai, K.J., Cox, D., et al., for the Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol 42 (2003), 1739–1746.
49. 49 Krumholz, H.M., Bradley, E.H., Nallamothu, B.K., et al. A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality. J Am Coll Cardiol Intv 1 (2008), 97–104.
50. 50 Krumholz, H.M., Herrin, J., Miller, L.E., et al. Improvements in door-to-balloon time in the United States, 2005 to 2010. Circulation 124 (2011), 1038–1045.
51. 51 Fonarow, G.C., Zhao, X., Smith, E.E., et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 311 (2014), 1632–1640.
52. 52 Menon, B.K., Saver, J.L., Goyal, M., et al. Trends in endovascular therapy and clinical outcomes within the nationwide Get With The Guidelines-Stroke registry. Stroke 46 (2015), 989–995.
53. 53 Hassan, A.E., Chaudhry, S.A., Grigoryan, M., et al. National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era. Stroke 43 (2012), 3012–3017.
54. 54 Zaidat, O.O., Lazzaro, M., McGinley, E., et al. Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy. Neurology 79 (2012), S35–S41.
55. 55 Adeoye, O., Albright, K.C., Carr, B.G., et al. Geographic access to acute stroke care in the United States. Stroke 45 (2014), 3019–3024.
56. 56 Alberts, M.J., Latchaw, R.E., Selman, W.R., et al., for the Brain Attack Coalition. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 36 (2005), 1597–1616.
57. 57 Mullen, M.T., Branas, C.C., Kasner, S.E., et al. Optimization modeling to maximize population access to comprehensive stroke centers. Neurology 84 (2015), 1196–1205.